Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

it has become apparent that they face challenges stemming from datasets that span more spatial dimensions. In fact, the best-performing clustering algorithms scale linearly in the number of points, ...

With the Open To Work feature, you can privately tell recruiters or publicly share with the LinkedIn community that you are looking for new job opportunities. Sending messages to people you know ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

This project has not set up a SECURITY.md file yet.